Cargando…

Cytosponge-TFF3 Testing can Detect Precancerous Mucosal Changes of the Stomach

Gastric intestinal metaplasia (GIM) and gastric atrophy (GA) are associated with increased risk of gastric cancer and are indications for endoscopic surveillance when affecting the proximal stomach.(1) Endoscopic screening is not cost-effective in areas with low-moderate incidence of gastric cancer(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadjinicolaou, ANDREAS V., Azizi, ALEXANDER A., O’Donovan, MARIA, Debiram, IRENE, Fitzgerald, REBECCA C., Di Pietro, MASSIMILIANO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders for the American Gastroenterological Association 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130737/ https://www.ncbi.nlm.nih.gov/pubmed/34358719 http://dx.doi.org/10.1016/j.cgh.2021.07.047

Ejemplares similares

Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
por: di Pietro, Massimiliano, et al.
Publicado: (2020)

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
por: Offman, Judith, et al.
Publicado: (2018)

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
por: Fitzgerald, Rebecca C, et al.
Publicado: (2020)

Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial
por: Ghimire, Bhagabati, et al.
Publicado: (2023)

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
por: Maroni, Roberta, et al.
Publicado: (2022)

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot
por: Pilonis, Nastazja Dagny, et al.
Publicado: (2022)

Early Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress
por: Fitzgerald, Rebecca C., et al.
Publicado: (2017)

Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility study
por: Jones, Christopher M., et al.
Publicado: (2022)

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study
por: Xu, Yiwang, et al.
Publicado: (2019)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning
por: Berman, Adam G., et al.
Publicado: (2022)

Computational pathology aids derivation of microRNA biomarker signals from Cytosponge samples
por: Masqué-Soler, Neus, et al.
Publicado: (2022)

Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study
por: Katzka, David A, et al.
Publicado: (2017)

Molecular Alterations in the Stomach of Tff1-Deficient Mice: Early Steps in Antral Carcinogenesis
por: Znalesniak, Eva B., et al.
Publicado: (2020)

Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes
por: Gullo, Irene, et al.
Publicado: (2020)

Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data
por: Swart, Nicholas, et al.
Publicado: (2021)

Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
por: Freeman, Madeleine, et al.
Publicado: (2017)

Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
por: Masuda, Mia Y., et al.
Publicado: (2022)

The Interaction of Helicobacter pylori with TFF1 and Its Role in Mediating the Tropism of the Bacteria Within the Stomach
por: Clyne, Marguerite, et al.
Publicado: (2019)

The Forms of the Lectin Tff2 Differ in the Murine Stomach and Pancreas: Indications for Different Molecular Functions
por: Znalesniak, Eva B., et al.
Publicado: (2023)

Comparison of the Anatomic Distribution of Stomach Cancer and Precancerous Gastric Lesions
por: You, Wei‐cheng, et al.
Publicado: (1992)

Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
por: Ishibashi, Yuko, et al.
Publicado: (2017)

Validation of the DNA Methylation Landscape of TFF1/TFF2 in Gastric Cancer
por: Qian, Ze, et al.
Publicado: (2022)

The Development of Spasmolytic Polypeptide/TFF2-Expressing Metaplasia (SPEM) During Gastric Repair Is Absent in the Aged Stomach
por: Engevik, Amy C., et al.
Publicado: (2016)

Modified endoscopic mucosal resection techniques for treating precancerous colorectal lesions
por: Tziatzios, Georgios, et al.
Publicado: (2021)

Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population
por: Jin, Eun-Heui, et al.
Publicado: (2015)

Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging
por: Lopes, Catarina, et al.
Publicado: (2023)

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens
por: Chettouh, Hamza, et al.
Publicado: (2018)

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study
por: Kadri, Sudarshan R, et al.
Publicado: (2010)

Uncommon mucosal metastases to the stomach
por: Kanthan, R, et al.
Publicado: (2009)

Primary Mucosal Melanoma of the Stomach
por: Phillips, O., et al.
Publicado: (2018)

HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma
por: Timofte, Andrei Daniel, et al.
Publicado: (2021)

Differential Expression of TFF1 and TFF3 in Patients Suffering from Chronic Rhinosinusitis with Nasal Polyposis
por: Mihalj, Martina, et al.
Publicado: (2019)

Immunohistochemical Detection of Human Telomerase Reverse Transcriptase in Normal Mucosa and Precancerous Lesions of the Stomach
por: Yasui, Wataru, et al.
Publicado: (1999)

Expression Profiling along the Murine Intestine: Different Mucosal Protection Systems and Alterations in Tff1-Deficient Animals
por: Salm, Franz, et al.
Publicado: (2023)

Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis
por: Im, Soyoung, et al.
Publicado: (2012)

Confocal endomicroscopy diagnostic criteria for early signet-ring cell carcinoma in hereditary diffuse gastric cancer
por: Pilonis, Nastazja D., et al.
Publicado: (2023)

A88 EVALUATING THE ACCEPTABILITY AND EFFICACY OF CYTOSPONGE FOR BARRETT'S ESOPHAGUS: A SINGLE CENTRE CROSS-SECTIONAL STUDY
por: Alqattan, A E, et al.
Publicado: (2023)

Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer
por: Wu, Cheng-Shyong, et al.
Publicado: (2016)

A novel TFF2 splice variant (ΔEX2TFF2) correlates with longer overall survival time in cholangiocarcinoma
por: KAMLUA, SURASEE, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4a8omg44db1gqav21vqjsajson